Below are the most recent publications written about "Transplant Recipients" by people in Profiles.
-
Tripathi S, Jul? AM, Zhuo Z, Schreiber BL, Martin-Moreno PL, Sui SH, Waaga-Gasser AM, Chandraker A. Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. Sci Rep. 2026 Jan 14; 16(1):3619.
-
Anwar IJ, DeLaura I, Ladowski JM, Schilir? D, Gao Q, Manook M, Yoon J, Belloni R, Park A, Schuster DJ, Song M, Lin L, Farris AB, Magnani D, Williams K, Kwun J, Knechtle SJ. CD154 blockade effectively controls antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients. Sci Transl Med. 2025 Jan; 17(779):eadn8130.
-
L?pez-Medrano F, Carver PL, Rutjanawech S, Aranha-Camargo LF, Fernandes R, Belga S, Daniels SA, Mueller NJ, Burkhard S, Theodoropoulos NM, Postma DF, van Duijn PJ, Arnaiz de Las Revillas F, P?rez Del Molino-Bernal C, Hand J, Lowe A, Bodro M, Vanino E, Fern?ndez-Cruz A, Ramos-Mart?nez A, Makek MJ, Bou Mjahed R, Manuel O, Kamar N, Calvo-Cano A, Rueda-Carrasco L, Mu?oz P, ?lvarez-Ur?a A, P?rez-Recio S, Sab? N, Rodr?guez-?lvarez R, Silva JT, Mularoni A, Vidal E, Alonso-Titos J, Del Rosal T, Classen AY, Goss CW, Agarwal M, Mej?a-Chew C. Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study. Transplantation. 2025 02 01; 109(2):e134-e141.
-
Halleck F, B?hmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sj?holm K, Runstr?m A, Lef?vre P, Tollemar J, Jordan S. A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection. Clin Transplant. 2024 07; 38(7):e15383.
-
Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transpl. 2024 08 01; 30(8):848-861.
-
Chandraker A, Regmi A, Gohh R, Sharma A, Woodle ES, Ansari MJ, Nair V, Chen LX, Alhamad T, Norman S, Cibrik D, Singh M, Alper A, Jain D, Zaky Z, Knechtle S, Sharfuddin A, Gupta G, Lonze BE, Young JH, Adey D, Faravardeh A, Dadhania DM, Rossi AP, Florescu D, Cardarelli F, Ma J, Gilmore S, Vasileiou S, Jindra PT, Wojciechowski D. Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
-
Massicotte-Azarniouch D, Detwiler RK, Hu Y, Falk RJ, Saha MK, Hogan SL, Derebail VK. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis. Nephrol Dial Transplant. 2023 08 31; 38(9):2009-2018.
-
Kilduff S, Hayde N, Viswanathan S, Reidy K, Abramowitz MK. Metabolic acidosis in pediatric kidney transplant recipients. Pediatr Nephrol. 2023 12; 38(12):4165-4173.
-
Trepanowski N, Kim DY, Hartman RI. Nicotinamide for Skin-Cancer Chemoprevention in Transplantation. N Engl J Med. 2023 06 29; 388(26):2493-2494.
-
Kyriazis PP, Agarwal KA, Pavlakis M. Optimizing Arteriovenous Fistula Care in Kidney Transplant Recipients: A Complex Task. Clin J Am Soc Nephrol. 2023 10 01; 18(10):1366-1368.